Ziltivekimab
3 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
🔮 fades ✓
Novo Nordisk faces a divergent clinical outlook as its pediatric obesity trials succeed while heart drug programs for CKD suffer setbacks.
5 sources
5 articles
v 3
44d ago
◼ Archived
Business
🔮 fades ✗
Novo Nordisk has halted two clinical trials for Ziltivekimab, an experimental cardiovascular drug designed to reduce inflammation.
1 sources
1 articles
v 0
45d ago
◼ Archived
Business
🔮 fades ✓
Novo Nordisk has terminated two additional phase 3 trials of its cardiovascular drug ziltivekimab due to futility, impacting its growth strategy.
5 sources
5 articles
v 3
46d ago
\n
\n
\n